{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T18:31:35Z","timestamp":1767983495287,"version":"3.49.0"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2008,1,3]],"date-time":"2008-01-03T00:00:00Z","timestamp":1199318400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2008,4]]},"DOI":"10.1007\/s10067-007-0800-1","type":"journal-article","created":{"date-parts":[[2008,1,2]],"date-time":"2008-01-02T14:18:18Z","timestamp":1199283498000},"page":"511-513","source":"Crossref","is-referenced-by-count":62,"title":["Anti-cyclic citrullinated peptide-2 (CCP2) autoantibodies and extra-articular manifestations in Greek patients with rheumatoid arthritis"],"prefix":"10.1007","volume":"27","author":[{"given":"Ioannis","family":"Alexiou","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anastasios","family":"Germenis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Athanasios","family":"Koutroumpas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anastasia","family":"Kontogianni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katerina","family":"Theodoridou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lazaros I.","family":"Sakkas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2008,1,3]]},"reference":[{"key":"800_CR1","first-page":"54","volume":"48","author":"SE Gabriel","year":"2003","unstructured":"Gabriel SE, Crowson CS, Kremers HM et al (2003) Survival in rheumatoid arthritis. A population-based analysis of trends over 40 years. Arthritis Rheum 48:54\u20138","journal-title":"A population-based analysis of trends over 40 years. Arthritis Rheum"},{"key":"800_CR2","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.1136\/ard.2004.033571","volume":"64","author":"J Ronnelid","year":"2005","unstructured":"Ronnelid J, Wick MC, Lampa J et al (2005) Longitudinal analysis of citrullinated protein\/peptide antibodies (anti-CCP) during 5 year follow up in early rheumatoid arthritis: anti-CCP status predicts worse disease activity and greater radiological progression. Ann Rheum Dis 64:1744\u201349","journal-title":"Ann Rheum Dis"},{"key":"800_CR3","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1136\/ard.2006.054445","volume":"66","author":"C Turesson","year":"2007","unstructured":"Turesson C, Jacobsson LTH, Sturfelt G et al (2007) Rheumatoid factor and antibodies to cyclic citrullinated peptides are associated with severe extra-articular manifestations in rheumatoid arthritis. Ann Rheum Dis 66:59\u201364","journal-title":"Ann Rheum Dis"},{"key":"800_CR4","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.1002\/art.20316","volume":"50","author":"FA Gaalen van","year":"2004","unstructured":"van Gaalen FA, van Aken J, Huizinga TWJ et al (2004) Association between HLA class II genes and autoantibodies to cyclic citrullinated peptides (CCPs) influence the severity of rheumatoid arthritis. Arthritis Rheum 50:2113\u201321","journal-title":"Arthritis Rheum"},{"key":"800_CR5","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1002\/art.21739","volume":"54","author":"AH Helm-van Mil Van der","year":"2006","unstructured":"Van der Helm-van Mil AH, Verpoort KN, Breedveld FC et al (2006) The HLA-DRB1 shared epitope alleles are primarily a risk factor for anti-cyclic citrullinated peptide antibodies and are not an independent risk factor to develop rheumatoid arthritis. Arthritis Rheum 54:1117\u201321","journal-title":"Arthritis Rheum"},{"key":"800_CR6","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1002\/art.1780350706","volume":"35","author":"KA Boki","year":"1992","unstructured":"Boki KA, Panayi GS, Vaughan RW et al (1992) HLA-class II sequence polymorphisms and susceptibility to rheumatoid arthritis in Greeks. The HLA-DR beta shared epitope accounts for the disease in only a minority of Greeks. Arthritis Rheum 35:749\u201355","journal-title":"Arthritis Rheum"},{"key":"800_CR7","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/1471-2474-8-37","volume":"8","author":"I Alexiou","year":"2007","unstructured":"Alexiou I, Germenis A, Ziogas A et al (2007) Diagnostic value of anti-cyclic citrullinated peptide antibodies in Greek patients with rheumatoid arthritis. BMC Musculoskelet Disord 8:37\u201343","journal-title":"BMC Musculoskelet Disord"},{"key":"800_CR8","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1093\/rheumatology\/kei111","volume":"45","author":"AJW Zendman","year":"2006","unstructured":"Zendman AJW, van Venrooij WJ, Pruijn GJM (2006) Use and significance of anti-CCP autoantibodies in rheumatoid arthritis. Rheumatology 45:20\u201325","journal-title":"Rheumatology"},{"key":"800_CR9","doi-asserted-by":"crossref","first-page":"816","DOI":"10.7326\/0003-4819-146-11-200706050-00008","volume":"146","author":"K Nishimura","year":"2007","unstructured":"Nishimura K, Sugiyama D, Kogata Y et al (2007) Meta-analysis: diagnostic accuracy of anti-cyclic citrullinated peptide antibody and rheumatoid a factor for rheumatoid arthritis. Ann Intern Med 146:816\u20137","journal-title":"Ann Intern Med"},{"key":"800_CR10","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1136\/ard.2003.017574","volume":"63","author":"L Rycke De","year":"2004","unstructured":"De Rycke L, Peene I, Hoffman IEA et al (2004) Rheumatoid factor and anti-citrullinated protein antibodies in rheumatoid arthritis: diagnostic value, associations with radiological progression rate, and extra-articular manifestations. Ann Rheum Dis 63:1587\u201393","journal-title":"Ann Rheum Dis"},{"key":"800_CR11","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1016\/j.clinbiochem.2006.06.004","volume":"39","author":"C Korkmaz","year":"2006","unstructured":"Korkmaz C, Us T, Kasifoglu T, Akgun Y (2006) Anti-cyclic citrullinated peptide (CCP) antibodies in patients with long-standing rheumatoid arthritis and their relationship with extra-articular manifestations. Clin Biochem 39:961\u20135","journal-title":"Clin Biochem"},{"key":"800_CR12","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1002\/art.21575","volume":"54","author":"L Klareskog","year":"2006","unstructured":"Klareskog L, Stolt P, Lundendberg K et al (2006) A new model for the etiology of rheumatoid arthritis: smoking may trigger HLA-DR (shared epitope)-restricted immune reaction to autoantigens modified by citrullination. Arthritis Rheum 54:38\u201346","journal-title":"Arthritis Rheum"},{"key":"800_CR13","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1002\/art.22597","volume":"56","author":"M Pedersen","year":"2007","unstructured":"Pedersen M, Jacobsen S, Garred P et al (2007) Strong combined gene-environment effects in anti-cyclic citrullinated peptide-positive rheumatoid arthritis. A nationwide case-control study in Denmark. Arthritis Rheum 56:1446\u201353","journal-title":"Arthritis Rheum"},{"key":"800_CR14","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1093\/rheumatology\/36.1.141","volume":"36","author":"C Stavropoulos","year":"1997","unstructured":"Stavropoulos C, Spyropoulou M, Koumantaki Y et al (1997) HLA-DRB1* genotypes in Greek rheumatoid arthritis patients: association with disease characteristics, sex and age at onset. Br J Rheumatol 36:141\u20132","journal-title":"Br J Rheumatol"},{"key":"800_CR15","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1136\/ard.55.3.190","volume":"55","author":"AE Voskuyl","year":"1996","unstructured":"Voskuyl AE, Zwinderman AH, Westedt ML et al (1996) Factors associated with the development of vasculitis in rheumatoid arthritis: results of a case-control study. Ann Rheum Dis 55:190\u20132","journal-title":"Ann Rheum Dis"},{"key":"800_CR16","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1136\/ard.2003.014647","volume":"63","author":"C Alessandri","year":"2004","unstructured":"Alessandri C, Bombardieri M, Papa N et al (2004) Decrease of anti-cyclic citrullinated peptide antibodies and rheumatoid factor following anti-TNF\u03b1 therapy (infliximab) in rheumatoid arthritis is associated with clinical improvement. Ann Rheum Dis 63:1218\u201321","journal-title":"Ann Rheum Dis"},{"key":"800_CR17","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1007\/s00296-004-0571-9","volume":"26","author":"P Caramaschi","year":"2005","unstructured":"Caramaschi P, Biasi D, Tonolli E et al (2005) Antibodies against cyclic citrullinated peptides in patients with rheumatoid arthritis before and after infliximab treatment. Rheumatol Int 26:58\u201362","journal-title":"Rheumatol Int"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-007-0800-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10067-007-0800-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-007-0800-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,29]],"date-time":"2019-05-29T08:51:11Z","timestamp":1559119871000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10067-007-0800-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,1,3]]},"references-count":17,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2008,4]]}},"alternative-id":["800"],"URL":"https:\/\/doi.org\/10.1007\/s10067-007-0800-1","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,1,3]]}}}